David Sambian

发表

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Kwaku Poku Asante, M. Tanner, K. Marsh, 2012, The New England journal of medicine.

Surveillance and laboratory collaboration in response to an outbreak of Vibrio parahaemolyticus, Plesiomonas shigelloides, and Aeromonas hydrophila in Sekondi-Takoradi, Ghana: a case series

David Sambian, D. Opare, E. K. Mensah, 2022, Journal of Medical Case Reports.

Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children

Kwaku Poku Asante, M. Demoitié, S. Owusu-Agyei, 2009, PloS one.

Laboratory capacity in COVID-19 diagnosis and the need to enhance molecular testing in Ghana

David Sambian, D. Opare, M. Owusu, 2021, Global Security: Health, Science and Policy.

Common bacteria in sputum or gastric lavage of patients presenting with signs and symptoms of lower respiratory tract infections

David Sambian, Sylvester A Mensah, M. Owusu, 2021, The Pan African medical journal.

Phase Ii, Randomized Trial to Assess the Safety and Immunogenicity of the Candidate Malaria Vaccines Rts,S/As02 and Rts,S/As01 When Given According to Different Vaccination Schedules in Children in Ghana

Kwaku Poku Asante, M. Demoitié, S. Owusu-Agyei, 2008 .

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Pedro Alonso, Trudie Lang, Bernhards Ogutu, 2011, The New England journal of medicine.

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial

O. Traoré, S. Adjei, H. Tinto, 2020, Human Vaccines & Immunotherapeutics.

Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study

Vysaul B. Nyirongo, Anna E. Jeffreys, M. Pirinen, 2018, The Lancet. Haematology.

Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

O. Traoré, S. Adjei, H. Tinto, 2018, Human vaccines & immunotherapeutics.

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

S. Adjei, M. Oneko, K. Otieno, 2022, The Lancet. Infectious diseases.

Capillary refill time as an independent prognostic indicator in severe and complicated malaria.

K. Osei-Kwakye, D. Ansong, T. Agbenyega, 2006, The Journal of pediatrics.

Haematological indices, nutritional assessment and mortality outcome of children presenting with severe malaria to a tertiary hospital in Ghana

D. Ansong, J. Sylverken, David Sambian, 2013 .

T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children

Kwaku Poku Asante, S. Owusu-Agyei, D. Dosoo, 2011, PloS one.

Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial.

Kwaku Poku Asante, S. Adjei, S. Owusu-Agyei, 2020, Vaccine.